BIOMAT Database Logo BIOMAT Database Logo

[Anticoagulant therapy. I. (Possibilities and limits)]. 1970

M Fischer

UI MeSH Term Description Entries
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006496 Heparinoids Heparin derivatives. The term has also been used more loosely to include naturally occurring and synthetic highly-sulphated polysaccharides of similar structure. Heparinoid preparations have been used for a wide range of applications including as anticoagulants and anti-inflammatories and they have been claimed to have hypolipidemic properties. (From Martindale, The Extra Pharmacopoeia, 30th, p232) Ateroid,Atheroid,Heparinoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms

Related Publications

M Fischer
[Crohn disease: I. Possibilities and limits of conservative therapy].
January 1984, Langenbecks Archiv fur Chirurgie,
M Fischer
[Insulin therapy. Possibilities and limits].
July 1990, Medizinische Monatsschrift fur Pharmazeuten,
M Fischer
[Possibilities and limits of segmental therapy].
May 1953, Die Medizinische,
M Fischer
[Possibilities and limits of intralymphatic therapy].
August 1970, Rassegna internazionale di clinica e terapia,
M Fischer
[Oral diabetes therapy. Possibilities and limits].
April 1981, Der Internist,
M Fischer
[Possibilities and limits of cellular therapy].
November 1955, Munchener medizinische Wochenschrift (1950),
M Fischer
Limits and possibilities of physical therapy.
March 1948, Nederlands tijdschrift voor geneeskunde,
M Fischer
[Possibilities and limits of neoplasm drug therapy].
July 1972, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
M Fischer
[Tremor. Possibilities and limits of drug therapy].
January 1990, Medizinische Monatsschrift fur Pharmazeuten,
M Fischer
[Group therapy in gerontopsychiatry, limits and possibilities].
January 1977, Psychiatrie, Neurologie, und medizinische Psychologie,
Copied contents to your clipboard!